MXPA06002666A - Cristal de compuesto heterociclico. - Google Patents
Cristal de compuesto heterociclico.Info
- Publication number
- MXPA06002666A MXPA06002666A MXPA06002666A MXPA06002666A MXPA06002666A MX PA06002666 A MXPA06002666 A MX PA06002666A MX PA06002666 A MXPA06002666 A MX PA06002666A MX PA06002666 A MXPA06002666 A MX PA06002666A MX PA06002666 A MXPA06002666 A MX PA06002666A
- Authority
- MX
- Mexico
- Prior art keywords
- methyl
- degree
- crystals
- crystal
- oxazol
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 4
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- IMYPSTHZBIWMNA-UHFFFAOYSA-N 2-methyl-5-[4-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]butyl]-1,3-dioxane-2-carboxylic acid Chemical compound CC=1OC(C=2C=CC(C)=CC=2)=NC=1CCCCC1COC(C)(C(O)=O)OC1 IMYPSTHZBIWMNA-UHFFFAOYSA-N 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000002050 diffraction method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El proposito principal de la invencion es proporcionar un nuevo cristal especifico del acido 2-metil- c-5-[4-[5-metil- 2-(4-metilfenil)-1, 3-oxazol-4 -il]butil]-1, 3-dioxano- r-2-carboxilico. La invencion incluye, por ejemplo, un cristal del acido 2-metil-c- 5-[4-[5-metil- 2-(4-metilfenil)-1, 3-oxazol-4 -il]butil]-1, 3-dioxano-r -2-carboxilico, la cual tiene picos a los angulos de difraccion de al menos 12.4??, 17.1??, y 20.8 degree en un espectro de difraccion de rayos X en polvo, y un agente preventivo o terapeutico que comprende el cristal como un ingrediente activo para su uso en las enfermedades de las arterias coronarias, infarto cerebral, hiperlipemia, arterioesclerosis, diabetes mellitus, hipertension, u obesidad.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003320556 | 2003-09-12 | ||
| PCT/JP2004/013209 WO2005026160A1 (ja) | 2003-09-12 | 2004-09-10 | 複素環化合物の結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06002666A true MXPA06002666A (es) | 2006-06-06 |
Family
ID=34308606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06002666A MXPA06002666A (es) | 2003-09-12 | 2004-09-10 | Cristal de compuesto heterociclico. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070027198A1 (es) |
| EP (1) | EP1666479A1 (es) |
| JP (1) | JPWO2005026160A1 (es) |
| KR (1) | KR20060123087A (es) |
| CN (1) | CN1849317A (es) |
| AU (1) | AU2004272428A1 (es) |
| BR (1) | BRPI0414274A (es) |
| CA (1) | CA2538425A1 (es) |
| MX (1) | MXPA06002666A (es) |
| RU (1) | RU2006111451A (es) |
| WO (1) | WO2005026160A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102014103827A1 (de) * | 2014-03-20 | 2015-09-24 | Thyssenkrupp Ag | Antriebsvorrichtung zum Antrieb eines Werkzeugschiebers in einer Falzanlage |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2410382A1 (en) * | 2000-05-26 | 2002-11-25 | Nippon Shinyaku Co., Ltd. | Heterocyclic compounds |
-
2004
- 2004-09-10 BR BRPI0414274-8A patent/BRPI0414274A/pt not_active Application Discontinuation
- 2004-09-10 AU AU2004272428A patent/AU2004272428A1/en not_active Abandoned
- 2004-09-10 JP JP2005513906A patent/JPWO2005026160A1/ja active Pending
- 2004-09-10 RU RU2006111451/04A patent/RU2006111451A/ru not_active Application Discontinuation
- 2004-09-10 CN CNA2004800263020A patent/CN1849317A/zh active Pending
- 2004-09-10 CA CA002538425A patent/CA2538425A1/en not_active Abandoned
- 2004-09-10 EP EP04787849A patent/EP1666479A1/en not_active Withdrawn
- 2004-09-10 MX MXPA06002666A patent/MXPA06002666A/es unknown
- 2004-09-10 WO PCT/JP2004/013209 patent/WO2005026160A1/ja not_active Ceased
- 2004-09-10 KR KR1020067004807A patent/KR20060123087A/ko not_active Withdrawn
- 2004-09-10 US US10/571,368 patent/US20070027198A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0414274A (pt) | 2006-11-07 |
| JPWO2005026160A1 (ja) | 2007-11-08 |
| WO2005026160A1 (ja) | 2005-03-24 |
| AU2004272428A1 (en) | 2005-03-24 |
| RU2006111451A (ru) | 2006-07-27 |
| EP1666479A1 (en) | 2006-06-07 |
| CN1849317A (zh) | 2006-10-18 |
| CA2538425A1 (en) | 2005-03-24 |
| US20070027198A1 (en) | 2007-02-01 |
| KR20060123087A (ko) | 2006-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325074D1 (de) | Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält | |
| NO20060636L (no) | Trisubstituerte aryl og heteroarylderivater som modulatorer av metabolisme og profylakse og behandling av lidelser relatert til dette | |
| IL160945A (en) | 4, 5 - diarylthiazole - 2 - carboxamides having cb1 - antagonistic, agonistic or partial agonistic activity and use thereof for the preparation of pharmaceutical compositions | |
| WO2005044192A3 (en) | Triazole compounds and uses related thereto | |
| CA2474578A1 (en) | Novel pyridin- and pyrimidin-derivatives | |
| DE60226764D1 (de) | Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase | |
| NO20054852L (no) | GFAT inhibitorer | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20051103L (no) | Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer | |
| TW200505919A (en) | DPP-IV inhibitors | |
| CA2464068A1 (en) | .alpha.-form or .beta.-form crystal of (r)-2-(2-aminothiazol-4yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl)acetanilide | |
| NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
| BR0308904A (pt) | Método de tratamento de gastroparesia, e, uso de um composto de glp-1 | |
| CA2472954A1 (en) | Aza-arylpiperazines | |
| CA2454022A1 (en) | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis | |
| NO20075399L (no) | Benzimidazolerivat og anvendelse derav | |
| EA200101121A1 (ru) | Полиморф 5-[4-[2-(n-метил-n-(2-пиридил) амино) этокси] бензил] тиазолидин-2,4-диона, соли малеиновой кислоты | |
| EA200101119A1 (ru) | Новый фармацевтический препарат | |
| WO2007015999A3 (en) | Process for synthesizing a substituted pyrazole | |
| NO20052182L (no) | Nye forbindelser | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| MX2009005619A (es) | Formas poliformicas del deferasirox (icl670a). | |
| MXPA06002666A (es) | Cristal de compuesto heterociclico. | |
| NO20025659D0 (no) | Heterocykliske forbindelser |